当前位置: X-MOL 学术ACS Pharmacol. Transl. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir”
ACS Pharmacology & Translational Science Pub Date : 2021-04-29 , DOI: 10.1021/acsptsci.1c00106
Ting Chen, Cheng-Yin Fei, Yi-Ping Chen, Karen Sargsyan, Jian-Jong Liang, Chun-Che Liao, Yi-Ling Lin, Chun-Ping Chang, Hanna S. Yuan, Carmay Lim

In the original manuscript, the authors Jian-Jong Liang, Chun-Che Liao, and Yi-Ling Lin were not listed. These three authors had performed the cell-based experiments in Figure 5b,c but were mistakenly listed in the acknowledgment section. The author list and affiliations should appear as in this Correction. This article has not yet been cited by other publications.

中文翻译:

更正“使用双硫仑/依布硒啉和瑞德西韦协同抑制 SARS-CoV-2 复制”

在原稿中,作者没有列出梁建钟、廖春车和林奕玲。这三位作者在图 5b、c 中进行了基于细胞的实验,但被错误地列在了致谢部分。作者列表和隶属关系应出现在本更正中。这篇文章还没有被其他出版物引用。
更新日期:2021-06-11
down
wechat
bug